Table 2.
Charge Category | 12-Month Average Cost ($) |
Comparison of Cost |
|||
---|---|---|---|---|---|
On Pathway (n = 1,095) | Off Pathway (n = 314) | Cost Difference ($; on − off) | Cost Ratio (on/off) | 95% CI* for Cost Ratio | |
Outpatient visits | 1,124 | 1,060 | 64 | 1.06 | 0.99 to 1.11 |
Acute care visits | 437 | 364 | 73 | 1.20 | 0.95 to 1.46 |
Chemotherapy | 11,839 | 18,762 | −6,923 | 0.63 | 0.55 to 0.76 |
Other medication | 4,374 | 7,198 | −2,824 | 0.61 | 0.52 to 0.74 |
ESAs | 1,011 | 1,867 | −856 | 0.54 | 0.42 to 0.69 |
CSFs | 1,867 | 2,951 | −1,083 | 0.63 | 0.52 to 0.83 |
Laboratory procedures | 223 | 295 | −73 | 0.75 | 0.67 to 0.84 |
Minor procedures | 33 | 43 | −10 | 0.78 | 0.66 to 0.92 |
Nursing care/hospice | 2.68 | 2.16 | 0.52 | 1.24 | 0.14 to 15.20 |
Other | 1.25 | 0.99 | 0.25 | 1.25 | 0.39 to 9.04 |
G codes | 7.86 | 11.94 | −4.08 | 0.66 | 0.40 to 1.27 |
Total cost | 18,042 | 27,737 | −9,695 | 0.65 | 0.58 to 0.76 |
Abbreviations: ESA, erythropoietin stimulating agent; CSF, WBC growth factor.
95% CIs calculated using percentile method using 10,000 bootstrap samples.